NPCE

NeuroPace
NPCE

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$293.76M
EV
$303.14M
Shares Outstanding
33.68M
Beta
1.90

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$16.75
P/E 2025E
-
P/Revenue 2025E
3.07x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About NeuroPace, Inc.

gainify
NPCE

NeuroPace, Inc.

NPCE

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy...

Sector

Healthcare

Industry

Medical - Devices

CEO

Becker, Joel

Employees

209

IPO Date

2021-04-22

Headquarters

455 North Bernardo Avenue, Mountain View, California, 94043, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.